PsychNostics
Stage
Incubator/Accelerator | AliveAbout PsychNostics
PsychNostics, LLC has developed a diagnostic blood test for Bipolar Disorder and ADHD. This propreitory test uses the Membrane Potential Ratio ( MPR ) as a diagnostic blood test marker for Bipolar Disorder (BPD) and Attention Deficit Hyper Active Disorder (ADHD). The test results have been published in peer reviewed scientific journals. Clinical psychiatrists have validated the reliability of this test through clinical trials. PsychNostics, LLC is currently engaged in the development of broader uses of this technology nationwide. Further research is underway to elucidate the biological pathway and the proteins involved so that they could be used as drug targets for developing more effective drugs for these illnesses. Efforts are being made to partner co-development and marketing arrangements with other companies to develop these technologies.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
PsychNostics Patents
PsychNostics has filed 9 patents.
The 3 most popular patent topics include:
- Amphetamine
- Psychiatric diagnosis
- Abnormal psychology
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
9/26/2016 | 7/30/2019 | Ion channels, Electrophysiology, Psychiatric diagnosis, Neurophysiology, Transcription factors | Grant |
Application Date | 9/26/2016 |
|---|---|
Grant Date | 7/30/2019 |
Title | |
Related Topics | Ion channels, Electrophysiology, Psychiatric diagnosis, Neurophysiology, Transcription factors |
Status | Grant |
PsychNostics Frequently Asked Questions (FAQ)
Where is PsychNostics's headquarters?
PsychNostics's headquarters is located at Baltimore.
What is PsychNostics's latest funding round?
PsychNostics's latest funding round is Incubator/Accelerator.
Who are the investors of PsychNostics?
Investors of PsychNostics include bwtech@UMBC.
Who are PsychNostics's competitors?
Competitors of PsychNostics include Ikonisys, iMMCO Diagnostics, ContraVac, Affinergy, Daktari Diagnostics and 10 more.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Compare PsychNostics to Competitors
Lumiphore is a research company developing lanthanide technology for use in high-value applications and commercializing the technology by entering into market-specific alliances with corporate partners. Lumiphore develops and markets biological detection systems based on luminescent lanthanide complexes, which provide a combination of sensitivity, reliability, flexibility and high throughput.
ProterixBio develops products to transform the management of chronic diseases.
IMMCO Diagnostics provides high-quality diagnostic test kits and lab testing services worldwide for the screening of autoimmune disorders. IMMCO Diagnostics incorporates working on research, clinical laboratory expertise, and medical devices into an approach to autoimmune diagnostics.
Clinical Laboratory Partners is a provider of clinical diagnostic testing services for healthcare providers, both hospitals and private practices, effectively competing in local markets against a range of national and other local clinical diagnostic laboratories.
Diamics, Inc. is a medical device and diagnostics company. The company is developing, manufacturing, and marketing cost effective cancer diagnostic systems that will increase long-term cancer survival rates through early detection.
Knoesis seeks to develop bio-analytical hardware and reagents enabling cost-effective clinical diagnostics. The vision of the company is to allow everyone affordable access to rapid and specific diagnostic healthcare knowledge. Knoesis' first application is an immunosensor for the detection of latent tuberculosis infection.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
